PubMed · 1992 · 149 citations · 26 references
MedicineBiochemistryPathologyHistologyHistopathologyNeuromuscular DisordersAmyloid FormationInclusion Body MyositisMuscle DisordersMuscle PathologyMuscle TissueProtein LocalizationAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloidogenic ProteinsAmyloidosis HistopathologyElectron Microscopy Of MuscleInclusion Body LesionsMicroscopic Morphology
In 11 of 11 inclusion-body myositis (IBM) patients, including one hereditary case, vacuolated muscle fibers contained large and multiple small inclusions immunoreactive for beta-amyloid protein (beta AP). All IBM muscle biopsies had characteristic cytoplasmic tubulo-filaments (CTFs) by electron microscopy. None of 14 control muscle biopsies contained the beta AP immunoreactive (IR) inclusions characteristic of IBM. On the light microscopy level, beta AP-IR inclusions colocalized with ubiquitin immunoreactivity. By immunogold electronmicroscopy, beta AP immunoreactivity was localized to a) amorphous, poorly defined structures, b) dense floccular material, c) clusters of loosely packed amyloidlike fibrils 6-8 nm in diameter, and d) poorly defined loose fibrillar structures 6-8 nm in diameter. beta AP immunoreactive structures were often in proximity to CTFs, but CTFs themselves never contained beta AP-IR. Our study provides the first demonstration of beta AP accumulations in abnormal human muscle. This finding suggests that in addition to Alzheimer's disease, Down syndrome, and Dutch-type hereditary cerebrovascular amyloidosis, beta AP may play an important role in the pathogenesis of other diseases, including ones outside the central nervous system, for example, IBM.
26
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Jie Kang, Hans-Georg Lemaire, Axel Unterbeck et al. · Nature · 1987 · 4.6K citations
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
Marinos C. Dalakas · New England Journal of Medicine · 1991 · 944 citations
Medicine, Immunology, Pathology +12